TY  - GEN
AU  - Khanim,F
AU  - Davies,N
AU  - Veliça,P
AU  - Hayden,R
AU  - Ride,J
AU  - Pararasa,C
AU  - Chong,M G
AU  - Gunther,U
AU  - Veerapen,N
AU  - Winn,P
AU  - Farmer,R
AU  - Trivier,E
AU  - Rigoreau,L
AU  - Drayson,M
AU  - Bunce,C
TI  - Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
SN  - 1532-1827
PY  - 2014///0715
KW  - 3-Hydroxysteroid Dehydrogenases
KW  - antagonists & inhibitors
KW  - Aldo-Keto Reductase Family 1 Member C3
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Drug Interactions
KW  - Enzyme Inhibitors
KW  - pharmacology
KW  - Female
KW  - Humans
KW  - Hydroxyprostaglandin Dehydrogenases
KW  - Leukemia
KW  - Male
KW  - Mass Spectrometry
KW  - Medroxyprogesterone Acetate
KW  - Prostatic Neoplasms
KW  - Substrate Specificity
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2014.83
ER  -